Sino Biopharmaceutical reports stable share capital in October

Sino Biopharmaceutical Limited has released its monthly return on movements in securities for the period ended October 31, 2025. The company's authorized share capital stood at HK$750,000,000, comprising 30,000,000,000 ordinary shares with a par value of HK$0.025 each. There were no increases or decreases in the authorized share capital during the month.

The total number of issued ordinary shares also held steady at 18,760,717,230, with no changes reported for October 2025.

Furthermore, the report confirms no movements under the share option scheme, nor any other agreements or arrangements to issue shares. No funds were raised from the exercise of options in October 2025. The company reaffirmed that all statutory and listing requirements for its securities are met.